Feature | November 15, 2013| Dave Fornell, DAIC editor

Micro Pacemaker May Help Revolutionize Electrophysiology

nanostim pacemaker, SJM

It was just a couple years ago in a session at the American College of Cardiology on possible science-fiction-type cardiac technologies of the future that I first saw a slide of experimental, tiny catheter-delivered pacemakers that may some day revolutionize the field of electrophysiology (EP). In October, one of those science fiction devices, the Nanostim pacemaker, was granted market clearance in Europe and it was announced the vendor is in discussions to enter U.S clinical trials. I’m sure it is the first of many new miniaturized EP devices to come that will significantly change how patients with arrhythmias are treated.

When attending cardiology conferences, I am always on the lookout for “sexy” new technologies.  This admittedly is sometimes difficult to find among a sea of academic sessions and vendors on the expo floor who are always attempting to peddle what they perceive to be the greatest invention since sliced bread. However, the Nanostim is definitely one of those rare sexy technologies that we usually only find in the fictional worlds of futuristic Hollywood movies.

The tiny device, about the size of the head of a pen, can be delivered via a delivery catheter through the venous system and placed directly into the myocardium of the right ventricle.  The system eliminates the need for surgery to create a pocket under the skin for the device, or to install traditional leads.  This greatly simplifies the procedure and reduces the risk of potential complications such as infection, or the need to remove old leads years in the future. The simplified procedure cuts implant time down to an average of 28 minutes. 

One of the biggest issues facing EP is device battery life, as patients live longer or have devices implanted at a younger age. Even with miniaturization, Nanostim’s battery is expected to have an average lifespan of more than nine years at 100 percent pacing, or more than 13 years at 50 percent. 

Speaking of battery replacement, another advantage of the system is that it was designed to be fully retrievable so it can be readily repositioned during the implant procedure, or later retrieved for normal battery replacement.

What I find more intriguing are the possibilities this type of device may have on simplifying the practice of EP, possibly offering a way to more efficiently treat larger numbers of patients at a lower cost.  The delivery of this type of device might also open the possibility of implants by new operators, such as interventional cardiologists.  This might have the biggest impact in rural areas of the United States or in developing countries, where EP specialists are often rare.  

For more on the Nanostim and other EP technology developments in 2013 click here, or watch a video showing the Nanostim implantation procedure.

Related Content

News | Heart Failure| October 02, 2015
Cyberonics Inc. announced results from the extension of the ANTHEM-HF clinical study (ENCORE Study). Results of the...
AtriCure, cryoFORM cryoablation probe, launch
Technology | Ablation Systems| October 02, 2015
AtriCure Inc. launched the cryoFORM cryoablation probe, which offers increased probe flexibility to adapt to a variety...
predicting arrhythmias, mcgill university, alternans patterns
News | EP Lab| September 28, 2015
Researchers have discovered how to predict some cardiac arrhythmias several steps before they even occur. It’s a...
ACC, atrial fibrillation registries, ablation, left atrial appendage occlusion procedures, LAAO Registry
News | Atrial Fibrillation| September 24, 2015
The American College of Cardiology (ACC) launched two new clinical registry programs in August to track real-world...
Biotronik, NORDIC ICD trial, defibrillation testing, DF testing, shock efficacy
News | Implantable Cardioverter Defibrillators (ICD)| September 24, 2015
Biotronik announced the publication of NORDIC ICD (NO Regular Defibrillation testing In Cardioverter-Defibrillator...
guideline, treating supraventricular tachycardia, ACC, AHA, HRS
News | EP Lab| September 23, 2015
A new guideline aimed at helping clinicians treat patients with supraventricular tachycardia, or a rapid heart rate,...
MedLumics, OCT, real-time assessment, catheter ablation, atrial fibrillation
Feature | EP Mapping and Imaging Systems| September 17, 2015
MedLumics has announced the completion of a successful single-case pre-clinical feasibility study of its optical...
Texas Cardiac Arrhythmia Institute, TCAI, first in United States, EpiAccess System, epicardial ablation

Image courtesy of EpiEP

News | Ablation Systems| September 15, 2015
The Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center recently became the first facility in the...
Medtronic, Evera, ICD, MR-conditional, MRI, FDA approval
Technology | Implantable Cardioverter Defibrillators (ICD)| September 14, 2015
Medtronic received the first U.S. Food and Drug Administration (FDA) approval for an implantable cardioverter...
Texas Heart Institute, Rice University, grant, nanotubes, heart, electrical signals
Feature | EP Lab| September 14, 2015
Texas Heart Institute (THI) announced that it has received a prestigious American Heart Association grant alongside...
Overlay Init